| abstract |
The present invention relates to C-aryl glucoside derivatives, processes for their preparation and their use in medicine. In particular, the present invention relates to compounds of the formula I and their tautomers, enantiomers, diastereomers, racemates and pharmaceutically acceptable salts, processes for their preparation or the inclusion of such compounds A pharmaceutical composition, and the use as a therapeutic agent, particularly as a sodium-dependent glucose transporter (SGLT) inhibitor.n□ |